MagForce Nanotechnologies AG

Max-Planck-Straße 3
12489 Berlin
Germany

Contact

About MagForce Nanotechnologies

MagForce Nanotechnologies AG is the world's leading company in the field of nanotechnology-based cancer treatment.

Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of company presentation. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.

Read more about MagForce Nanotechnologies

Revolutionize your production: real-time Raman analysis for maximum efficiency

Efficient inline analysis for liquids and solids

User-friendly software for effortless Design of Experiments (DoE)

News about MagForce Nanotechnologies

21-Jun-2013 | business & finance

MagForce merges existing share classes

MagForce AG announced that the two different existing share classes have been prematurely merged, effective June 20, 2013. The new shares issued in the ...

Read news

04-Feb-2013 | research and development

MagForce starts research project with University of Bremen

MagForce AG announced the start of a research project with the University of Bremen, Center for Environmental Research and Sustainable Technology, for the ...

Read news

04-Oct-2012 | business & finance

MagForce to radically enforce market set up strategy with new management team

Core functions will be centralized in Munich

Read news

21-Aug-2012 | people

MagForce AG: Dr. Jan zur Hausen elected to the Supervisory Board of MagForce AG

MagForce AG announced that Dr. Jan zur Hausen was unanimously elected to the company's Supervisory Board at the Annual General Meeting. He is taking over ...

Read news

03-Nov-2011 | people

MagForce AG Announces Changes to Supervisory and Management Boards

MagForce AG announced the resignation of Prof. Dr. Walter Rust as chairman of the Supervisory Board as of October 25, 2011 due to health reasons. Effective ...

Read news

12-Oct-2011 | research and development

MagForce AG Announces Treatment of Recurrent Glioblastoma Patient with NanoTherm Therapy

MagForce AG announced the treatment of a recurrent glioblastoma patient with the company's NanoTherm® therapy. The first part of the therapy (instillation ...

Read news

22-Nov-2010 | research and development

MagForce Selected as Winner of 2010 STEP Award in the Category Product/Technology

Prize awarded in recognition of company's innovation and growth potential

Read news

18-Nov-2010 | people